Effect of monoclonal antibody therapy on the endogenous SARS-CoV-2 antibody response.

Clin Immunol · 2022 · PMC8866167 · PMID 35218964

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

At the seroconversion stage (10–19 days) anti-S IgM levels were reduced by >90% in BAM and CAS + IMD treated subjects compared to the untreated group, anti-N IgG levels trended lower but did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.